These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

816 related items for PubMed ID: 17072627

  • 1. Immunohistochemical study on topoisomerase IIalpha, Ki-67 and cytokeratin-19 in oral lichen planus lesions.
    Mattila R, Alanen K, Syrjänen S.
    Arch Dermatol Res; 2007 Jan; 298(8):381-8. PubMed ID: 17072627
    [Abstract] [Full Text] [Related]

  • 2. Significance of cell proliferation markers (Minichromosome maintenance protein 7, topoisomerase IIalpha and Ki-67) in cavital fluid cytology: can we differentiate reactive mesothelial cells from malignant cells?
    Kimura F, Kawamura J, Watanabe J, Kamoshida S, Kawai K, Okayasu I, Kuwao S.
    Diagn Cytopathol; 2010 Mar; 38(3):161-7. PubMed ID: 19821496
    [Abstract] [Full Text] [Related]

  • 3. Desmocollin expression in oral atrophic lichen planus correlates with clinical behavior and DNA content.
    Mattila R, Alanen K, Syrjänen S.
    J Cutan Pathol; 2008 Sep; 35(9):832-8. PubMed ID: 18422976
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Topoisomerase IIalpha mRNA and protein expression vs. in vitro drug resistance and clinical outcome in acute leukaemia.
    Uggla B, Tina E, Nahi H, Paul C, Höglund M, Sirsjö A, Tidefelt U.
    Int J Oncol; 2007 Jul; 31(1):153-60. PubMed ID: 17549416
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.
    Lee JJ, Kuo MY, Cheng SJ, Chiang CP, Jeng JH, Chang HH, Kuo YS, Lan WH, Kok SH.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):471-8. PubMed ID: 15772596
    [Abstract] [Full Text] [Related]

  • 9. DNA topoisomerase IIalpha in multiple myeloma: a marker of cell proliferation and not drug resistance.
    Wilson CS, Medeiros LJ, Lai R, Butch AW, McCourty A, Kelly K, Brynes RK.
    Mod Pathol; 2001 Sep; 14(9):886-91. PubMed ID: 11557785
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.
    Dingemans AM, Witlox MA, Stallaert RA, van der Valk P, Postmus PE, Giaccone G.
    Clin Cancer Res; 1999 Aug; 5(8):2048-58. PubMed ID: 10473085
    [Abstract] [Full Text] [Related]

  • 12. Expression of cyclooxygenase-2 and DNA topoisomerase II alpha in precancerous and cancerous lesions of the oral mucosa.
    Segawa E, Sakurai K, Kishimoto H, Takaoka K, Noguchi K, Hashitani S, Hirota S, Urade M.
    Oral Oncol; 2008 Jul; 44(7):664-71. PubMed ID: 17996482
    [Abstract] [Full Text] [Related]

  • 13. The topoisomerase IIalpha expression correlates with survival in patients with advanced Hodgkin's lymphoma.
    Provencio M, Corbacho C, Salas C, Millan I, Espana P, Bonilla F, Ramon Cajal S.
    Clin Cancer Res; 2003 Apr; 9(4):1406-11. PubMed ID: 12684412
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor.
    Tanoguchi K, Sasano H, Yabuki N, Kikuchi A, Ito K, Sato S, Yajima A.
    Mod Pathol; 1998 Feb; 11(2):186-93. PubMed ID: 9504690
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer.
    Gu C, Oyama T, Osaki T, Kohno K, Yasumoto K.
    Anticancer Res; 2001 Feb; 21(4A):2357-62. PubMed ID: 11724293
    [Abstract] [Full Text] [Related]

  • 18. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
    Vidal S, Kovacs K, Horvath E, Rotondo F, Kuroki T, Lloyd RV, Scheithauer BW.
    Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of DNA topoisomerase IIalpha expression in human hepatocellular carcinoma.
    Watanuki A, Ohwada S, Fukusato T, Makita F, Yamada T, Kikuchi A, Morishita Y.
    Anticancer Res; 2002 Nov; 22(2B):1113-9. PubMed ID: 12168909
    [Abstract] [Full Text] [Related]

  • 20. Expression of cell proliferation markers in pituitary adenomas--correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha.
    Wolfsberger S, Wunderer J, Zachenhofer I, Czech T, Böcher-Schwarz HG, Hainfellner J, Knosp E.
    Acta Neurochir (Wien); 2004 Aug; 146(8):831-9. PubMed ID: 15254805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.